AI Article Synopsis

  • Prolonged intense exercise can lead to temporary cardiac damage, and studying immunogenic cell damage markers may help understand this process.
  • Researchers tracked levels of various biomarkers (HMGB1, sRAGE, nucleosomes, hs-TnT, hs-CRP) in 51 adults at different intervals before and after a marathon.
  • They found significant increases in these markers immediately after the race, which typically returned to baseline within 24-72 hours, suggesting that the body experiences short-lived changes after intense physical activity rather than permanent damage.

Article Abstract

Prolonged and strenuous exercise has been linked to potential exercise-induced myocardial damages. One potential key to unmask the discussed underlying mechanisms of this subclinical cardiac damage could be markers of immunogenic cell damage (ICD). We investigated the kinetics of high-mobility group box 1 protein (HMGB1), soluble receptor for advanced glycation end products (sRAGE), nucleosomes, high sensitive troponin T (hs-TnT) and high sensitive C-reactive protein (hs-CRP) before and up to 12 weeks post-race and described associations with routine laboratory markers and physiological covariates. In our prospective longitudinal study, 51 adults (82% males; 43 ± 9 years) were included. All participants underwent a cardiopulmonary evaluation 10-12 weeks pre-race. HMGB1, sRAGE, nucleosomes, hs-TnT and, hs-CRP were analysed 10-12 weeks prior, 1-2 weeks before, immediately, 24 h, 72 h, and 12 weeks post-race. HMGB1, sRAGE, nucleosomes and hs-TnT increased significantly from pre- to immediately post-race (0.82-2.79 ng/mL; 1132-1388 pg/mL; 9.24-56.65 ng/mL; 6-27 ng/L; < 0.001) and returned to baseline within 24-72 h. Hs-CRP increased significantly 24 h post-race (0.88-11.5 mg/L; < 0.001). Change in sRAGE was positively associated with change in hs-TnT (rs = 0.352, = 0.011). Longer marathon finishing time was significantly associated with decreased levels of sRAGE [-9.2 pg/mL ( = -9.2, SE = 2.2, < 0.001)]. Prolonged and strenuous exercise increases markers of ICD immediately post-race, followed by a decrease within 72 h. An acute marathon event results in transient alterations of ICD, we assume that this is not solely driven by myocyte damages.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971726PMC
http://dx.doi.org/10.3389/fphys.2023.1118127DOI Listing

Publication Analysis

Top Keywords

srage nucleosomes
12
high-mobility group
8
group box
8
box protein
8
receptor advanced
8
advanced glycation
8
glycation products
8
prolonged strenuous
8
strenuous exercise
8
high sensitive
8

Similar Publications

Article Synopsis
  • Prolonged intense exercise can lead to temporary cardiac damage, and studying immunogenic cell damage markers may help understand this process.
  • Researchers tracked levels of various biomarkers (HMGB1, sRAGE, nucleosomes, hs-TnT, hs-CRP) in 51 adults at different intervals before and after a marathon.
  • They found significant increases in these markers immediately after the race, which typically returned to baseline within 24-72 hours, suggesting that the body experiences short-lived changes after intense physical activity rather than permanent damage.
View Article and Find Full Text PDF

Biomarkers associated with mortality in pediatric patients with cardiac arrest and acute respiratory distress syndrome.

Resuscitation

January 2022

Division of Critical Care Medicine, Department of Anesthesiology & Critical Care Medicine, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Leonard Davis Institute, University of Pennsylvania, Philadelphia, PA, USA.

Article Synopsis
  • The study aimed to identify plasma biomarkers linked to cardiac arrest in children with acute respiratory distress syndrome (ARDS) and evaluate their relationship with mortality rates in this group.
  • Researchers analyzed data from a cohort of 333 children, measuring 17 biomarkers, and found that eight were significantly elevated in those who experienced cardiac arrest alongside ARDS (ARDS + CA) compared to those with ARDS alone.
  • Key findings indicated that biomarkers sRAGE, IL-6, and granzyme B were associated with increased mortality in the ARDS + CA group, with sRAGE consistently showing higher levels in this cohort, even when controlling for illness severity.
View Article and Find Full Text PDF

Relevance of Circulating Nucleosomes, HMGB1 and sRAGE for Prostate Cancer Diagnosis.

In Vivo

June 2021

Institute of Laboratory Medicine, Munich Biomarker Research Center, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.

Background/aim: Evasion from cell death occurs in prostate cancer (PCa). We verified whether serum levels of cell death markers can have diagnostic value in PCa.

Patients And Methods: A total of 233 men scheduled for prostate biopsy [prostate specific antigen (PSA) level: 2-10 ng/ml] were enrolled.

View Article and Find Full Text PDF

Serum biomarkers are urgently needed for patient stratification and efficient treatment monitoring in pancreatic cancer (PC). Within a prospective diagnostic observation study, blood samples were obtained from 78 patients with advanced PC before and weekly during the course of palliative chemotherapy. Circulating nucleosomes and immunogenic cell death markers, high-mobility group box 1 (HMGB1), soluble receptors of advanced glycation end products (sRAGE) and DNAse activity, were measured by enzyme-linked immunosorbent assay and correlated with results of radiological staging after 2 months of treatment, with time to progression (TTP) and overall survival (OS).

View Article and Find Full Text PDF

Introduction: Immunogenic cell death markers are released from apoptotic and necrotic cells upon pathologic or therapeutic causes and stimulate the innate and adaptive immune system. Cell death products such as nucleosomes, damage-associated molecular pattern (DAMP) molecules such as the high-mobility group box 1 protein (HMGB1) and its receptor of advanced glycation end products (sRAGE) are supposed to play an essential role in driving this process. However, this immunogenic activation may have dual effects, either by sensitizing the immune system for more efficient tumor cell removal or by creating a favorable tumor microenvironment that facilitates tumor growth, proliferation and invasiveness.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!